Cheema Sanjay, Garr Edmund, Mehta Dwij, Chapman Miles, Hart Melanie, Lunn Michael P, Iodice Valeria, Matharu Manjit Singh
Headache and Facial Pain Group, University College London (UCL) Queen Square Institute of Neurology, London, United Kingdom.
Neuroimmunology and CSF Laboratory, University College London Hospitals NHS Trust, London, United Kingdom.
Front Neurol. 2025 Apr 1;16:1547124. doi: 10.3389/fneur.2025.1547124. eCollection 2025.
New daily persistent headache (NDPH) is a poorly understood headache disorder which often begins after a viral infection and has been hypothesised to have an immune basis. Several studies have found differences in peripheral serum cytokine levels between healthy controls and patients with other primary headache disorders such as migraine. We sought to measure peripheral levels of cytokines and chemokines in NDPH, chronic migraine (CM), and healthy controls, to identify any changes which could be biomarkers of inflammation in NDPH.
We performed an observational prospective case control study measuring serum cytokine levels in three age and sex matched groups of 40 patients each: patients with NDPH, patients with CM with similar headache frequency and severity, and healthy controls. We accounted for confounders such as infective or autoimmune illness, vaccinations, comorbidities, and medications. We used a 30-PLEX human cytokine immunoassay to measure the concentration of 30 cytokines and chemokines. The primary outcome measures were differences in median concentrations of TNF-, IL-6, and IL-8 between the three groups, as these are the three cytokines found to differ between chronic migraine and healthy controls in a recent meta-analysis.
Age and sex distribution was balanced between the groups. The NDPH and daily CM groups were balanced on headache frequency, severity, and duration. The concentration of IL-6 was higher in both NDPH (median 0.603 pg/mL) and CM (median 0.642 pg/mL), than in healthy controls (median 0.399 pg/mL), but there was no difference between the NDPH and CM groups. There were no significant differences in TNF-, IL-8, or any of the other cytokines tested between the three groups.
Peripheral cytokine levels do not appear to be helpful biomarkers in differentiating NDPH from daily CM, and the lack of differences to healthy controls does not lend support to the hypothesis of neuroinflammation being involved in the pathophysiology of NDPH.
新发性每日持续性头痛(NDPH)是一种了解甚少的头痛疾病,通常在病毒感染后起病,据推测有免疫基础。多项研究发现,健康对照与偏头痛等其他原发性头痛疾病患者的外周血清细胞因子水平存在差异。我们试图测量NDPH、慢性偏头痛(CM)患者及健康对照者外周血中细胞因子和趋化因子水平,以确定可能作为NDPH炎症生物标志物的任何变化。
我们开展了一项观察性前瞻性病例对照研究,测量三组年龄和性别匹配的患者(每组40例)的血清细胞因子水平:NDPH患者、头痛频率和严重程度相似的CM患者以及健康对照者。我们考虑了感染性或自身免疫性疾病、疫苗接种、合并症和药物等混杂因素。我们使用30种细胞因子人免疫分析方法来测量30种细胞因子和趋化因子的浓度。主要观察指标是三组之间肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)和白细胞介素-8(IL-8)的中位数浓度差异,因为在最近一项荟萃分析中发现这三种细胞因子在慢性偏头痛患者和健康对照者之间存在差异。
各组间年龄和性别分布均衡。NDPH组和每日发作的CM组在头痛频率、严重程度和持续时间方面均衡。NDPH组(中位数0.603 pg/mL)和CM组(中位数0.642 pg/mL)的IL-6浓度均高于健康对照者(中位数0.399 pg/mL),但NDPH组和CM组之间无差异。三组之间TNF-α、IL-8或其他任何检测的细胞因子均无显著差异。
外周细胞因子水平似乎无助于区分NDPH和每日发作的CM,与健康对照者无差异也不支持神经炎症参与NDPH病理生理过程的假说。